We are pleased to share the latest issue of LEAP magazine where the Alberta Cancer Foundation (ACF) features Clinical Trials 101. When it comes to clinical trials, Alberta is a leader in the country. These trials are essential to finding new ways to treat, detect and prevent cancer and improve the quality of life for cancer patients. In this issue, ACF takes a closer look at clinical trials and explore the cutting-edge research and studies making a significant impact on diagnoses and patient outcomes.
The Fall 2021 LEAP issue is also filled with stories and accomplishment from Alberta Cancer Clinical Trials (ACCT) Leadership; Dr. Randeep Sangha - Director, Clinical Trials Unit, Cross Cancer Institute and Dr. Jose Monzon – Director, Clinical Research Unit, Tom Baker Cancer Centre. They also highlight some of our programs such as Investigator-initiated trials.
We would like to thank the Alberta Cancer Foundation for sharing these stories of inspiration and progress. We are privileged to work alongside them to provide the best treatment and care for cancer patients and families.
Sign up for the Alberta Cancer Foundation eNewsletter. You’ll receive monthly stories about Albertans facing cancer and their families as well as inspiring other Albertans. eNewsletter | Alberta Cancer Foundation
This month's eNewsletter featured Project Exercise for Cancer to Enhance Living Well (EXCEL) is a 5-year Canada-wide project, led by Dr. Nicole Culos-Reed, PhD. The project is funded by the Alberta Cancer Foundation, Canadian Institute of Health Research and the Canadian Cancer Society.
Click the link below to read more and watch a video to hear from the participants themselves as they describe their experiences with the program and discuss the positive impacts of adding more movement into their lives.
We are pleased to share the latest issue of LEAP magazine where the Alberta Cancer Foundation (ACF) explores the concept of ‘Survivorship.’ For many Albertans facing cancer, their journey doesn’t end when treatment does. This issue highlights some of the latest resources, studies and supports in place that help cancer survivors and ‘thrivers’ navigate their new normal.
We are pleased to share the latest Winter 2021 Progress Report from the Alberta Cancer Foundation (ACF). ACF is proud to share some examples of the exciting work taking place right here in Alberta.
The Phase I-II Niacin in Neuro Glioblastoma trial is scheduled to open at the Tom Baker Cancer Centre in the Spring of 2021. This trial is based on the University of Calgary researchers' discovery of a new tactic to stop the growth of the deadly brain cancer. Findings indicate the body may be the ultimate weapon against glioblastoma, but it needs help.
